Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP405875.RAYIZx2pimOqjEXIeJxN8OjeoALvl9wJ3fPl1DEWxg16U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP405875.RAYIZx2pimOqjEXIeJxN8OjeoALvl9wJ3fPl1DEWxg16U130_assertion type Assertion NP405875.RAYIZx2pimOqjEXIeJxN8OjeoALvl9wJ3fPl1DEWxg16U130_head.
- NP405875.RAYIZx2pimOqjEXIeJxN8OjeoALvl9wJ3fPl1DEWxg16U130_assertion description "[Therefore FoxO3a might become a pursuable target to be suitably exploited in combination therapies either in ER?+ or ER?- breast tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP405875.RAYIZx2pimOqjEXIeJxN8OjeoALvl9wJ3fPl1DEWxg16U130_provenance.
- NP405875.RAYIZx2pimOqjEXIeJxN8OjeoALvl9wJ3fPl1DEWxg16U130_assertion evidence source_evidence_literature NP405875.RAYIZx2pimOqjEXIeJxN8OjeoALvl9wJ3fPl1DEWxg16U130_provenance.
- NP405875.RAYIZx2pimOqjEXIeJxN8OjeoALvl9wJ3fPl1DEWxg16U130_assertion SIO_000772 24047697 NP405875.RAYIZx2pimOqjEXIeJxN8OjeoALvl9wJ3fPl1DEWxg16U130_provenance.
- NP405875.RAYIZx2pimOqjEXIeJxN8OjeoALvl9wJ3fPl1DEWxg16U130_assertion wasDerivedFrom befree-20150227 NP405875.RAYIZx2pimOqjEXIeJxN8OjeoALvl9wJ3fPl1DEWxg16U130_provenance.
- NP405875.RAYIZx2pimOqjEXIeJxN8OjeoALvl9wJ3fPl1DEWxg16U130_assertion wasGeneratedBy ECO_0000203 NP405875.RAYIZx2pimOqjEXIeJxN8OjeoALvl9wJ3fPl1DEWxg16U130_provenance.